Donghoon Kang

13PUBLICATIONS
25CO-AUTHORS
Medical infection agents (incl. prions)Industrial molecular engineering of nucleic acids and proteinsComparative and cross-cultural education
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 15, 2026
Genomic and Clinical Features Associated with Reduced Susceptibility to Cefiderocol and Cross-resistance to β-lactam/β-lactamase Inhibitors in a Global Cohort of Pseudomonas aeruginosa.

|Feb 12, 2026
Loss of the ferripyochelin receptor FptA drives reduced cefiderocol susceptibility and impairs fitness in Pseudomonas aeruginosa PA14.

Donghoon Kang, Rodrigo P Baptista, Salvador I Drusin

|Sep 26, 2025
Loss of the Ferripyochelin Receptor FptA Drives Reduced Cefiderocol Susceptibility and Impairs Fitness in Pseudomonas aeruginosa PA14.

Donghoon Kang, Rodrigo P Baptista, Cesar A Arias

|Jul 18, 2025
Cefepime-zidebactam therapy for extensively drug-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae infection as a bridge to liver transplantation.

Shemual Tsai, Masayuki Nigo, Donghoon Kang

|Sep 30, 2024
A functional screen for ubiquitin regulation identifies an E3 ligase secreted by Pseudomonas aeruginosa.

Cameron G Roberts, Supender Kaur, Aaron J Ogden

|Feb 23, 2024
Cytotoxic rhamnolipid micelles drive acute virulence in Pseudomonas aeruginosa.

Qi Xu, Donghoon Kang, Matthew D Meyer

Pageof 3

Frequent Collaborators

8 joint publications

Natalia V Kirienko

4 joint publications

William R Miller

3 joint publications

Cesar A Arias

3 joint publications

Rodrigo P Baptista